Effects of Conditioning Regimens and T Cell Depletion in Hematopoietic Cell Transplantation for Primary Immune Deficiency

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 12, 2012, Pages 1911-1920

  Triplett, Brandon M ^a,b   Wang, Chong ^a   Yang, Jie ^a   Dallas, Mari ^a,b   Hartford, Christine ^a   Howard, Vanessa ^a   Pillai, Asha ^a,b   Shook, David ^a,b   Srinivasan, Ashok ^a,b   Laver, Joseph ^a,b   Leung, Wing ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Immune reconstitution; Severe combined immune deficiency

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; FLUDARABINE; MELPHALAN; OKT 3; THIOTEPA;

ADOLESCENT; ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CHILD; CLINICAL ASSESSMENT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOCOMPETENCE; IMMUNOMAGNETIC SEPARATION; INFECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; REDUCED INTENSITY CONDITIONING; SCHOOL CHILD; SEVERE COMBINED IMMUNODEFICIENCY; T CELL DEPLETION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; LYMPHOCYTE DEPLETION; MALE; RETROSPECTIVE STUDIES; SEVERE COMBINED IMMUNODEFICIENCY; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84869093665     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.07.014     Document Type: Article

References (30)

1. Gatti R.A., Meuwissen H.J., Allen H.D., et al. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968, 2:1366-1369.
2. Bach F.H., Albertini R.J., Joo P., et al. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet 1968, 2:1364-1366.
3. Hacein-Bey-Abina S., Le Deist F., Carlier F., et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002, 346:1185-1193.
4. Buckley R.H. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 2004, 22:625-655.
5. Antoine C., Muller S., Cant A., et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 2003, 361:553-560.
6. Buckley R.H., Schiff S.E., Schiff R.I., et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999, 340:508-516.
7. Patel N.C., Chinen J., Rosenblatt H.M., et al. Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioning. J Allergy Clin Immunol 2009, 124:1062-1069.
8. Cavazzana-Calvo M., Carlier F., Le Deist F., et al. Long-term T-cell reconstitution after hematopoietic stem cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype. Blood 2007, 109:4575-4581.
9. Friedrich W., Honig M., Muller S.M. Long-term follow-up in patients with severe combined immunodeficiency treated by bone marrow transplantation. Immunol Res 2007, 38:165-173.
10. Shizuru J.A., Bhattacharya D., Cavazzana-Calvo M. The biology of allogeneic hematopoietic cell resistance. Biol Blood Marrow Transplant 2010, 16:S2-S7.
11. Dvorak C.C., Cowan M.J. Hematopoietic stem cell transplantation for primary immunodeficiency disease. Bone Marrow Transplant 2008, 41:119-126.
12. Ozyurek E., Cowan M.J., Koerper M.A., et al. Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders. Bone Marrow Transplant 2008, 42:83-91.
13. Rao K., Amrolia P.J., Jones A., et al. Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood 2005, 105:879-885.
14. Ozsahin H., Cavazzana-Calvo M., Notarangelo L.D., et al. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation. Blood 2008, 111:439-445.
15. Howard V., Myers L.A., Williams D.A., et al. Stem cell transplants for patients with X-linked agammaglobulinemia. Clin Immunol 2003, 107:98-102.
16. Kaplan E.L., Meier P. Nonparametric-estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
17. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966, 50:163-170.
18. Griffith L.M., Cowan M.J., Kohn D.B., et al. Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. J Allergy Clin Immunol 2008, 122:1087-1096.
19. Leung W., Ahn H., Rose S.R., et al. A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation. Medicine (Baltimore) 2007, 86:215-224.
20. Sanders J.E. Growth and development after hematopoietic cell transplant in children. Bone Marrow Transplant 2008, 41:223-227.
21. Majhail N.S., Brazauskas R., Rizzo J.D., et al. Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. Blood 2011, 117:316-322.
22. Amrolia P., Gaspar H.B., Hassan A., et al. Nonmyeloablative stem cell transplantation for congenital immunodeficiencies. Blood 2000, 96:1239-1246.
23. Grunebaum E., Mazzolari E., Porta F., et al. Bone marrow transplantation for severe combined immune deficiency. JAMA 2006, 295:508-518.
24. Filipovich A.H., Stone J.V., Tomany S.C., et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 2001, 97:1598-1603.
25. Kernan N.A., Bartsch G., Ash R.C., et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993, 328:593-602.
26. Knutsen A.P., Steffen M., Wassmer K., et al. Umbilical cord blood transplantation in Wiskott Aldrich syndrome. J Pediatr 2003, 142:519-523.
27. Knutsen A.P., Wall D.A. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience. J Clin Immunol 2000, 20:466-476.
28. Reisner Y., Kapoor N., Kirkpatrick D., et al. Transplantation for severe combined immunodeficiency with HLA-A, -B, -D, -DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 1983, 61:341-348.
29. De Ravin S.S., Malech H.L. Partially corrected X-linked severe combined immunodeficiency: long-term problems and treatment options. Immunol Res 2009, 43:223-242.
30. Chen X., Hale G.A., Barfield R., et al. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies. Br J Haematol 2006, 135:524-532.